Table 4.
Parameter | eGFR < 60 | eGFR ≥ 60 | P-value | OR (95 % CI) | P-value |
---|---|---|---|---|---|
Uric acid quartiles | 0.047* | ||||
Q1 (187.00–325.00)* | 1 (4.54) | 36 (27.27) | Reference | ||
Q2 (325.10–400.00) | 5 (22.73) | 35 (26.52) | 5.14 (0.57–46.27) | 0.144 | |
Q3 (400.10–471.10) | 9 (40.91) | 30 (22.73) | 10.8 (1.29–90.16) | 0.028* | |
Q4 (471.20–708.40) | 7 (31.81) | 31 (23.48) | 8.13 (0.95–69.76) | 0.046 | |
UA:CR quartiles | < 0.001* | ||||
Q1 (1.82–3.43)* | 12 (54.55) | 23 (17.42) | Reference | ||
Q2 (3.44–4.06) | 6 (27.27) | 33 (25.00) | 0.35 (0.35–1.06) | 0.064 | |
Q3 (4.07–4.74) | 3 (13.64) | 38 (28.79) | 0.15 (0.04–0.59) | 0.007* | |
Q4 (4.75–7.09) | 1 (4.54) | 38 (28.79) | 0.05 (0.01–0.41) | 0.005* |